SlideShare ist ein Scribd-Unternehmen logo
1 von 5
Downloaden Sie, um offline zu lesen
Intensive Hemodialysis, Treatment
Complications and Tolerability
Morfin JA, Fluck RJ, Weinhandl ED, Kansal S, McCullough PA, Komenda P. Intensive
Hemodialysis and Treatment Complications and Tolerability. American Journal of
Kidney Diseases, Volume 68, Issue 5, S43 - S50.
1Caplin B, Kumar S, Davenport A. Patients’ perspective of haemodialysis-
associated symptoms. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -
Eur Ren Assoc. 2011;26(8):2656-2663. doi:10.1093/ndt/gfq763. 2Urquhart-Secord
R, Craig JC, Hemmelgarn B, et al. Patient and Caregiver Priorities for Outcomes in
Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis
Off J Natl Kidney Found. March 2016. doi:10.1053/j.ajkd.2016.02.037.
Many of the most commonly reported
symptoms among hemodialysis patients
and care partners were identified as being
more important than life expectancy.1,2
Symptoms identified as more
important included fatigue, drops in
blood pressure, and cramping.
CHAPTER 5, FIGURE 1:
Prevalence of commonly reported symptoms in a cohort of
550 hemodialysis patients.2
The cumulative incidence of intradialytic
hypotension was significantly lower with
intensive hemodialysis in both of the FHN
Trials compared to conventional
hemodialysis.1
1Kotanko P, Garg AX, Depner T, et al. Effects of frequent hemodialysis on blood
pressure: Results from the randomized frequent hemodialysis network trials.
Hemodial Int Int Symp Home Hemodial. 2015;19(3):386-401.
doi:10.1111/hdi.12255.
CHAPTER 5, FIGURE 2:
Incidence of levels I, II, and III intradialytic hypotension for
intensive versus conventional hemodialysis in the FHN
Daily Trial and the FHN Nocturnal Trial.1
Symptoms of intradialytic hypotension were classified into 3
categories: those that led to lowering of the UF rate or
reduced blood flow (Level I); those that led to the
administration of saline, but not to lowering of the UF rate
(Level II); and those that led to both the administration of
saline and lowering of the UF rate (Level III).
21%
REDUCTION
67%
REDUCTION
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
2.0
2.2
2.4
<2 h 2-6 h 7-12 h >12 h
Hazardratiosforall-causemortality
Reported recovery time (hours)
1Rayner HC, Zepel L, Fuller DS, et al. Recovery time, quality of life, and mortality in
hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study
(DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2014;64(1):86-94.
doi:10.1053/j.ajkd.2014.01.014.
Each 1-hour increment in post-dialysis
recovery time was associated with a 3% and
5% increased risk of hospitalization and
death respectively.1
Recovery time was from 2 to 6 hours in
41% of patients, from 7 to 12 hours in
17% of patients, and greater than 12
hours in 10% of patients.1
TABLE 4:
Hazard ratios for mortality by reported recovery time.
Dashed bars span one standard deviation above and below
the mean.
1.34
RELATIVE RISK
1.17
RELATIVE RISK
0.88
RELATIVE RISK
Mean post-dialysis recovery time fell
from 7.9 hours at baseline to 1.0 hours
at 4 months, and to 1.1 hours at 12
months.1
CHAPTER 5, FIGURE 4:
Mean post-dialysis recovery time in intention-to-treat and
per-protocol cohorts of the FREEDOM study.1
Dashed bars span one standard deviation above and below
the mean
1Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive
symptoms and postdialysis recovery time: interim report from the FREEDOM
(Following Rehabilitation, Economics and Everyday-Dialysis Outcome
Measurements) Study. Am J Kidney Dis Off J Natl Kidney Found. 2010;56(3):531-
539. doi:10.1053/j.ajkd.2010.04.019.
In FREEDOM Study, the percentage of
patients with recovery time less than 1 hour
increased from 19% at baseline to 65% after
12 months.1

Weitere ähnliche Inhalte

Was ist angesagt?

Advancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancingDialysis.org
 
Advancing Dialysis - Mineral and Bone Disease
Advancing Dialysis - Mineral and Bone DiseaseAdvancing Dialysis - Mineral and Bone Disease
Advancing Dialysis - Mineral and Bone Diseasenxstage
 
Advancing dialysis: Recasting kidney failure as cardiovascular disease
Advancing dialysis: Recasting kidney failure as cardiovascular diseaseAdvancing dialysis: Recasting kidney failure as cardiovascular disease
Advancing dialysis: Recasting kidney failure as cardiovascular diseaseAdvancingDialysis.org
 
Advancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis PatientsAdvancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis Patientsnxstage
 
Advancing dialysis multinational guidelines for increased time and frequency ...
Advancing dialysis multinational guidelines for increased time and frequency ...Advancing dialysis multinational guidelines for increased time and frequency ...
Advancing dialysis multinational guidelines for increased time and frequency ...AdvancingDialysis.org
 
Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...AdvancingDialysis.org
 
Advancing Dialysis - Quality of Life
Advancing Dialysis - Quality of LifeAdvancing Dialysis - Quality of Life
Advancing Dialysis - Quality of Lifenxstage
 
Advancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium PresentationAdvancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium PresentationAdvancingDialysis.org
 
Advancing Dialysis Recent Findings: PD first ... what's next?
Advancing Dialysis Recent Findings: PD first ... what's next?Advancing Dialysis Recent Findings: PD first ... what's next?
Advancing Dialysis Recent Findings: PD first ... what's next?AdvancingDialysis.org
 
Advancing age in liver transplant recipients
Advancing age in liver transplant recipientsAdvancing age in liver transplant recipients
Advancing age in liver transplant recipientshr77
 
Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...
Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...
Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...ijtsrd
 
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...Moh'd sharshir
 
Journal club edgt 2016 (1)
Journal club edgt 2016 (1)Journal club edgt 2016 (1)
Journal club edgt 2016 (1)sath_gasclub
 
Goal directed resuscitation for patients
Goal directed resuscitation for patientsGoal directed resuscitation for patients
Goal directed resuscitation for patientsDrJawad Butt
 
Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?
Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?
Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?Vein Global
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shockshivabirdi
 
Ckd mbd 2020 update prof. hussein sheashaa
Ckd mbd 2020 update prof. hussein sheashaaCkd mbd 2020 update prof. hussein sheashaa
Ckd mbd 2020 update prof. hussein sheashaaFAARRAG
 

Was ist angesagt? (20)

Advancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular Disease
 
Advancing Dialysis - Mineral and Bone Disease
Advancing Dialysis - Mineral and Bone DiseaseAdvancing Dialysis - Mineral and Bone Disease
Advancing Dialysis - Mineral and Bone Disease
 
Advancing dialysis: Recasting kidney failure as cardiovascular disease
Advancing dialysis: Recasting kidney failure as cardiovascular diseaseAdvancing dialysis: Recasting kidney failure as cardiovascular disease
Advancing dialysis: Recasting kidney failure as cardiovascular disease
 
Advancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis PatientsAdvancing dialysis - Improving Outcomes for Dialysis Patients
Advancing dialysis - Improving Outcomes for Dialysis Patients
 
Advancing dialysis multinational guidelines for increased time and frequency ...
Advancing dialysis multinational guidelines for increased time and frequency ...Advancing dialysis multinational guidelines for increased time and frequency ...
Advancing dialysis multinational guidelines for increased time and frequency ...
 
Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...Advancing dialysis.org recent findings better management of volume with inten...
Advancing dialysis.org recent findings better management of volume with inten...
 
Advancing Dialysis - Quality of Life
Advancing Dialysis - Quality of LifeAdvancing Dialysis - Quality of Life
Advancing Dialysis - Quality of Life
 
Advancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium PresentationAdvancingdialysis.org 2017 ASN Sponsored Symposium Presentation
Advancingdialysis.org 2017 ASN Sponsored Symposium Presentation
 
Advancing Dialysis Recent Findings: PD first ... what's next?
Advancing Dialysis Recent Findings: PD first ... what's next?Advancing Dialysis Recent Findings: PD first ... what's next?
Advancing Dialysis Recent Findings: PD first ... what's next?
 
Advancing age in liver transplant recipients
Advancing age in liver transplant recipientsAdvancing age in liver transplant recipients
Advancing age in liver transplant recipients
 
Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...
Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...
Comparison of Infection Episodes in CKD Patients with or without Hemodialysis...
 
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
Early goal-directed therapy in severe sepsis and septic shock: ProCESS, ARISE...
 
Lra lancet
Lra lancetLra lancet
Lra lancet
 
Journal club edgt 2016 (1)
Journal club edgt 2016 (1)Journal club edgt 2016 (1)
Journal club edgt 2016 (1)
 
Goal directed resuscitation for patients
Goal directed resuscitation for patientsGoal directed resuscitation for patients
Goal directed resuscitation for patients
 
Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?
Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?
Should C2 Disease Classification Be Broken Down Further? Who Progresses to C4?
 
Early Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic ShockEarly Goal-Directed Therapy in Septic Shock
Early Goal-Directed Therapy in Septic Shock
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Ckd mbd 2020 update prof. hussein sheashaa
Ckd mbd 2020 update prof. hussein sheashaaCkd mbd 2020 update prof. hussein sheashaa
Ckd mbd 2020 update prof. hussein sheashaa
 
Shortened hep c combo passes real world
Shortened hep c combo passes real worldShortened hep c combo passes real world
Shortened hep c combo passes real world
 

Andere mochten auch

Advancing Dialysis - Hypertension
Advancing Dialysis - HypertensionAdvancing Dialysis - Hypertension
Advancing Dialysis - Hypertensionnxstage
 
Advancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular Diseasenxstage
 
CHRONIC KIDNEY DISEASES
CHRONIC KIDNEY DISEASESCHRONIC KIDNEY DISEASES
CHRONIC KIDNEY DISEASESZayd Rafid
 
Ppi symposium muhsin
Ppi symposium muhsinPpi symposium muhsin
Ppi symposium muhsinShaikhani.
 
Git j club psc16.
Git j club psc16.Git j club psc16.
Git j club psc16.Shaikhani.
 
Ppi symposium hero
Ppi symposium heroPpi symposium hero
Ppi symposium heroShaikhani.
 
Perspectives in Peritoneal Dialysis
Perspectives in Peritoneal DialysisPerspectives in Peritoneal Dialysis
Perspectives in Peritoneal DialysisRichard McCrory
 
Ppi symposium alshekhani.
Ppi symposium alshekhani.Ppi symposium alshekhani.
Ppi symposium alshekhani.Shaikhani.
 
Ppi symposium araz.
Ppi symposium araz.Ppi symposium araz.
Ppi symposium araz.Shaikhani.
 
Immunoglobuins & their functions
Immunoglobuins & their functionsImmunoglobuins & their functions
Immunoglobuins & their functionsDr. Roshni Maurya
 
Ppi seminar hiwa.
Ppi seminar hiwa.Ppi seminar hiwa.
Ppi seminar hiwa.Shaikhani.
 
GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17 GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17 Shaikhani.
 
thyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawy
thyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawythyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawy
thyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed EsawyAHMED ESAWY
 
Autoimmune liver and pancreatic disease
Autoimmune liver and pancreatic diseaseAutoimmune liver and pancreatic disease
Autoimmune liver and pancreatic diseaseAhmed Ghany
 
Autoimmune pancreatitis
Autoimmune pancreatitisAutoimmune pancreatitis
Autoimmune pancreatitisSamir Haffar
 

Andere mochten auch (20)

Advancing Dialysis - Hypertension
Advancing Dialysis - HypertensionAdvancing Dialysis - Hypertension
Advancing Dialysis - Hypertension
 
Advancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular DiseaseAdvancing Dialysis - Cardiovascular Disease
Advancing Dialysis - Cardiovascular Disease
 
CHRONIC KIDNEY DISEASES
CHRONIC KIDNEY DISEASESCHRONIC KIDNEY DISEASES
CHRONIC KIDNEY DISEASES
 
Ppi symposium muhsin
Ppi symposium muhsinPpi symposium muhsin
Ppi symposium muhsin
 
Git j club psc16.
Git j club psc16.Git j club psc16.
Git j club psc16.
 
Ppi symposium hero
Ppi symposium heroPpi symposium hero
Ppi symposium hero
 
Kidney
KidneyKidney
Kidney
 
Perspectives in Peritoneal Dialysis
Perspectives in Peritoneal DialysisPerspectives in Peritoneal Dialysis
Perspectives in Peritoneal Dialysis
 
Ppi symposium alshekhani.
Ppi symposium alshekhani.Ppi symposium alshekhani.
Ppi symposium alshekhani.
 
Ppi symposium araz.
Ppi symposium araz.Ppi symposium araz.
Ppi symposium araz.
 
Immunoglobuins & their functions
Immunoglobuins & their functionsImmunoglobuins & their functions
Immunoglobuins & their functions
 
Ppi seminar hiwa.
Ppi seminar hiwa.Ppi seminar hiwa.
Ppi seminar hiwa.
 
Overview of peritoneal dialysis
Overview of peritoneal dialysisOverview of peritoneal dialysis
Overview of peritoneal dialysis
 
Autoimmune Pancreatitis
Autoimmune PancreatitisAutoimmune Pancreatitis
Autoimmune Pancreatitis
 
GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17 GIT Cholestatic AI HBD 17
GIT Cholestatic AI HBD 17
 
thyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawy
thyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawythyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawy
thyriod gland imaging part 2 (full story diffuse thyriod disease) Dr Ahmed Esawy
 
Pancreatitis autoinmune
Pancreatitis autoinmunePancreatitis autoinmune
Pancreatitis autoinmune
 
Autoimmune liver and pancreatic disease
Autoimmune liver and pancreatic diseaseAutoimmune liver and pancreatic disease
Autoimmune liver and pancreatic disease
 
Autoimmune pancreatitis
Autoimmune pancreatitisAutoimmune pancreatitis
Autoimmune pancreatitis
 
Ig g4 related renal disease
Ig g4 related renal diseaseIg g4 related renal disease
Ig g4 related renal disease
 

Ähnlich wie Advancing Dialysis - Symptoms During Dialysis

ICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal FailureICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal FailureGerard Fennessy
 
Renal failure and Quality ofLlife Indicators in Kidney Transplantation
Renal failure and Quality ofLlife Indicators in Kidney TransplantationRenal failure and Quality ofLlife Indicators in Kidney Transplantation
Renal failure and Quality ofLlife Indicators in Kidney Transplantationkomalicarol
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement TherapyShairil Rahayu
 
Understanding Renal Cell Carcinoma
Understanding Renal Cell CarcinomaUnderstanding Renal Cell Carcinoma
Understanding Renal Cell Carcinomafondas vakalis
 
Letter 2 Dr. Paul W. Corey
Letter 2 Dr. Paul W. CoreyLetter 2 Dr. Paul W. Corey
Letter 2 Dr. Paul W. Coreyfast.track
 
Ufpresenterslides
UfpresenterslidesUfpresenterslides
Ufpresenterslideshospital
 
Integrated renal replacement therapy
Integrated renal replacement therapyIntegrated renal replacement therapy
Integrated renal replacement therapyFarragBahbah
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalizationAnna Wu
 
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeilyIncremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeilyMNDU net
 
cardiorenal syndrome and its characteristics and complications and causes.pptx
cardiorenal syndrome and its characteristics and complications and causes.pptxcardiorenal syndrome and its characteristics and complications and causes.pptx
cardiorenal syndrome and its characteristics and complications and causes.pptxArunDeva8
 
Hepatorenal syndrome recent advances
Hepatorenal syndrome recent advancesHepatorenal syndrome recent advances
Hepatorenal syndrome recent advancesKushal Dp
 
Incremental dialysis mansoura
Incremental dialysis mansouraIncremental dialysis mansoura
Incremental dialysis mansouraFarragBahbah
 
Liquidos en el paciente septico
Liquidos en el paciente septicoLiquidos en el paciente septico
Liquidos en el paciente septicoAivan Lima
 
Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...
Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...
Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...lissett tarira cerezo
 
Indications of peritoneal dialysis
Indications of peritoneal dialysisIndications of peritoneal dialysis
Indications of peritoneal dialysisMuhammad Mohsin Riaz
 

Ähnlich wie Advancing Dialysis - Symptoms During Dialysis (20)

ICN Victoria: Botha on Acute Renal Failure
ICN Victoria: Botha on Acute Renal FailureICN Victoria: Botha on Acute Renal Failure
ICN Victoria: Botha on Acute Renal Failure
 
ICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal FailureICN VIctoria: John Botha on Critical Care Renal Failure
ICN VIctoria: John Botha on Critical Care Renal Failure
 
Renal failure and Quality ofLlife Indicators in Kidney Transplantation
Renal failure and Quality ofLlife Indicators in Kidney TransplantationRenal failure and Quality ofLlife Indicators in Kidney Transplantation
Renal failure and Quality ofLlife Indicators in Kidney Transplantation
 
Continuous Renal Replacement Therapy
Continuous Renal Replacement TherapyContinuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
 
HCQS in COVID era.pptx
HCQS in COVID era.pptxHCQS in COVID era.pptx
HCQS in COVID era.pptx
 
Understanding Renal Cell Carcinoma
Understanding Renal Cell CarcinomaUnderstanding Renal Cell Carcinoma
Understanding Renal Cell Carcinoma
 
Letter 2 Dr. Paul W. Corey
Letter 2 Dr. Paul W. CoreyLetter 2 Dr. Paul W. Corey
Letter 2 Dr. Paul W. Corey
 
Ufpresenterslides
UfpresenterslidesUfpresenterslides
Ufpresenterslides
 
Integrated renal replacement therapy
Integrated renal replacement therapyIntegrated renal replacement therapy
Integrated renal replacement therapy
 
Reduce the hospitalization
Reduce the hospitalizationReduce the hospitalization
Reduce the hospitalization
 
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
RELAX: Inhibidor de la fosfodiesterasa-5. Insuficiencia cardiaca con función ...
 
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeilyIncremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
Incremental Heamodialysis .. Who Fit ? - prof. Amir el-okeily
 
cardiorenal syndrome and its characteristics and complications and causes.pptx
cardiorenal syndrome and its characteristics and complications and causes.pptxcardiorenal syndrome and its characteristics and complications and causes.pptx
cardiorenal syndrome and its characteristics and complications and causes.pptx
 
Fluidos
FluidosFluidos
Fluidos
 
Hepatorenal syndrome recent advances
Hepatorenal syndrome recent advancesHepatorenal syndrome recent advances
Hepatorenal syndrome recent advances
 
Incremental dialysis mansoura
Incremental dialysis mansouraIncremental dialysis mansoura
Incremental dialysis mansoura
 
Ijmas 560
Ijmas 560Ijmas 560
Ijmas 560
 
Liquidos en el paciente septico
Liquidos en el paciente septicoLiquidos en el paciente septico
Liquidos en el paciente septico
 
Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...
Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...
Esophageal motor abnormalities in patients with scleroderma heterogeneity, ri...
 
Indications of peritoneal dialysis
Indications of peritoneal dialysisIndications of peritoneal dialysis
Indications of peritoneal dialysis
 

Kürzlich hochgeladen

epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Classmanuelazg2001
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfDivya Kanojiya
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfMyThaoAiDoan
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)MohamadAlhes
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamAkebom Gebremichael
 

Kürzlich hochgeladen (20)

epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Nutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience ClassNutrition of OCD for my Nutritional Neuroscience Class
Nutrition of OCD for my Nutritional Neuroscience Class
 
Role of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdfRole of medicinal and aromatic plants in national economy PDF.pdf
Role of medicinal and aromatic plants in national economy PDF.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdfCCSC6142 Week 3 Research ethics - Long Hoang.pdf
CCSC6142 Week 3 Research ethics - Long Hoang.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
Myelin Oligodendrocyte Glycoprotein antibody associated disease (MOGAD)
 
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom KidanemariamANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
ANEMIA IN PREGNANCY by Dr. Akebom Kidanemariam
 

Advancing Dialysis - Symptoms During Dialysis

  • 1. Intensive Hemodialysis, Treatment Complications and Tolerability Morfin JA, Fluck RJ, Weinhandl ED, Kansal S, McCullough PA, Komenda P. Intensive Hemodialysis and Treatment Complications and Tolerability. American Journal of Kidney Diseases, Volume 68, Issue 5, S43 - S50.
  • 2. 1Caplin B, Kumar S, Davenport A. Patients’ perspective of haemodialysis- associated symptoms. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2011;26(8):2656-2663. doi:10.1093/ndt/gfq763. 2Urquhart-Secord R, Craig JC, Hemmelgarn B, et al. Patient and Caregiver Priorities for Outcomes in Hemodialysis: An International Nominal Group Technique Study. Am J Kidney Dis Off J Natl Kidney Found. March 2016. doi:10.1053/j.ajkd.2016.02.037. Many of the most commonly reported symptoms among hemodialysis patients and care partners were identified as being more important than life expectancy.1,2 Symptoms identified as more important included fatigue, drops in blood pressure, and cramping. CHAPTER 5, FIGURE 1: Prevalence of commonly reported symptoms in a cohort of 550 hemodialysis patients.2
  • 3. The cumulative incidence of intradialytic hypotension was significantly lower with intensive hemodialysis in both of the FHN Trials compared to conventional hemodialysis.1 1Kotanko P, Garg AX, Depner T, et al. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials. Hemodial Int Int Symp Home Hemodial. 2015;19(3):386-401. doi:10.1111/hdi.12255. CHAPTER 5, FIGURE 2: Incidence of levels I, II, and III intradialytic hypotension for intensive versus conventional hemodialysis in the FHN Daily Trial and the FHN Nocturnal Trial.1 Symptoms of intradialytic hypotension were classified into 3 categories: those that led to lowering of the UF rate or reduced blood flow (Level I); those that led to the administration of saline, but not to lowering of the UF rate (Level II); and those that led to both the administration of saline and lowering of the UF rate (Level III). 21% REDUCTION 67% REDUCTION
  • 4. 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 <2 h 2-6 h 7-12 h >12 h Hazardratiosforall-causemortality Reported recovery time (hours) 1Rayner HC, Zepel L, Fuller DS, et al. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2014;64(1):86-94. doi:10.1053/j.ajkd.2014.01.014. Each 1-hour increment in post-dialysis recovery time was associated with a 3% and 5% increased risk of hospitalization and death respectively.1 Recovery time was from 2 to 6 hours in 41% of patients, from 7 to 12 hours in 17% of patients, and greater than 12 hours in 10% of patients.1 TABLE 4: Hazard ratios for mortality by reported recovery time. Dashed bars span one standard deviation above and below the mean. 1.34 RELATIVE RISK 1.17 RELATIVE RISK 0.88 RELATIVE RISK
  • 5. Mean post-dialysis recovery time fell from 7.9 hours at baseline to 1.0 hours at 4 months, and to 1.1 hours at 12 months.1 CHAPTER 5, FIGURE 4: Mean post-dialysis recovery time in intention-to-treat and per-protocol cohorts of the FREEDOM study.1 Dashed bars span one standard deviation above and below the mean 1Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis Off J Natl Kidney Found. 2010;56(3):531- 539. doi:10.1053/j.ajkd.2010.04.019. In FREEDOM Study, the percentage of patients with recovery time less than 1 hour increased from 19% at baseline to 65% after 12 months.1